Market Research Logo

Global Transcatheter Mitral Valve Replacement (TMVR) Market: Size & Forecasts (2016-2021)

Global Transcatheter Mitral Valve Replacement (TMVR) Market: Size & Forecasts (2016-2021)

Scope of the Report

The report entitled “Global Transcatheter Mitral Valve Replacement (TMVR) Market: Size, Trends & Forecasts (2016-2021)”, provides analysis of the global TMVR market, with detailed analysis of market size and growth, penetration, market share and economic impact of the industry. The analysis includes the market by value, by volume, by segments and by penetration.

The report also includes the detailed analysis of the regional TMVR market of the following regions: The US and Europe. The analysis in this segment is done by penetration, by segments, by value and by volume.

Furthermore, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall global TMVR market has also been forecasted for the years 2016-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Edward Lifesciences, Medtronic and Abbott are some of the key players operating in the global TMVR market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Country Coverage

US
Europe

Company Coverage

Edward Lifesciences Corporation
Medtronic
Abbott Laboratories, Inc.

Executive Summary

The mitral valve allows the passage to oxygenated blood from lest atrium (LA) to the left ventricle (LV) and prevent the backflow of blood back into the left atrium. Mitral Regurgitation (MR) is a valve disorder where during heart contraction, blood leaks backward through the mitral valve. This reduces the amount of blood pumped through the body, which leads to declining heart function and heart failure, over the time .

The causes of MR disease are congenital heart disorder, rheumatic fever, trauma, any other heart disease, radiation therapy, etc. The treatments available for MR disease are surgical repair, drug treatment and replacement. There are two types of MR: Degenerative MR (DMR) and Functional MR (FMR). The DMR and FMR can further be subdivided into many types.

There are different approaches for replacement surgery, depending upon the type of MR disease. The TMVR market is in very early stage at this moment, with many companies developing their TMVR devices. The commercial TMVR devices are expected to be launched in next 2-3 years.

Currently, the global TMVR market is in early stage, but is expected to increase at high growth rates during the forecasted period (2016-2021). The global TMVR market is supported by various growth drivers, such as aging population, high number of cases of congenital heart defects, rheumatic fever, low survival rate of surgical repair in FMR patients, etc. Yet, the market faces certain challenges, such as, complexity in design, success of repair surgery in DMR patients, high number of patients not referred for surgery, etc.


1. Executive Summary
2. Introduction
2.1 Heart Valves: An Overview
2.2 Mitral Regurgitation: An Overview
2.2.1 Transcatheter Mitral Valve Timeline
Table 1: Transcatheter Mitral Valve Timeline
2.2.2 Types of MR
Table A: Types of Mitral Regurgitation
2.2.3 MR Clinical Guidelines
Table B: MR Surgery Class and Level
Table 2: Transcatheter Mitral Valve Clinical Guidelines
2.3 Aortic Valve v/s Mitral Valve
Table C: Comparison of Aortic Valve and Mitral Valve
3. Global Market Analysis
3.1 Global Mitral Regurgitation Market: An Analysis
3.1.1 Global MR Market by Number of Patients
Table 3: Global MR Market by Number of Patients; 2014-2021 (Million)
3.1.2 Global MR Market by Patient Severity
Table 4: Global MR Market by Patient Severity and Eligibility for Treatment; 2014-2021
3.2 Global Degenerative Mitral Regurgitation Market: An Analysis
3.2.1 Global DMR Market by Number of Patients and Prevalence of TMVR
Table 5: Global DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021
Table 6: Global DMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2021
3.3 Global Functional Mitral Regurgitation Market: An Analysis
3.3.1 Global FMR Market by Number of Patients and Prevalence of TMVR
Table 7: Global FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021
Table 8: Global FMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2021
3.4 Global TMVR Market: An Analysis
3.4.1 Global TMVR Market by Value
Table 9: Global TMVR Market by Value; 2017-2021 (US$ Million)
3.4.2 Global TMVR Market by Volume
Table 10: Global TMVR Market by Volume; 2017-2021 (Units)
4. Regional Market Analysis
4.1 US TMVR Market: An Analysis
4.1.1 US MR Market by Number of Patients and Patient Severity
Table 11: US MR Market by Number of Patients; 2014-2021 (Million)
Table 12: US MR Market by Patient Severity; 2014-2021
4.1.2 US DMR Market by Number of Patients and Prevalence of TMVR
Table 13: US DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021
Table 14: US DMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2021
4.1.3 US FMR Market by Number of Patients and Prevalence of TMVR
Table 15: US FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021
Table 16: US FMR Market by Number of High Risk Patients and Prevalence of TMVR; 2014-2021
4.1.4 US TMVR Market by Value and Volume
Table 17: US TMVR Market by Value; 2016-2021 (US$ Million)
Table 18: US TMVR Market by Volume; 2016-2021 (Units)
4.2 Europe TMVR Market: An Analysis
4.2.1 Europe MR Market by Number of Patients and Patient Severity
Table 19: Europe MR Market by Number of Patients; 2014-2021 (Million)
Table 20: Europe MR Market by Patient Severity; 2014-2021 (Million)
4.2.2 Europe DMR Market by Number of Patients and Prevalence of TMVR
Table 21: Europe DMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021
Table 22: Europe High Risk DMR Market by Number of Patients and Prevalence of TMVR; 2014-2021 (‘000)
4.2.3 Europe FMR Market by Number of Patients and Prevalence of TMVR
Table 23: Europe FMR Market by Number of Patients Surgically Treated and Prevalence of TMVR; 2014-2021
Table 24: Europe High Risk FMR Market by Number of Patients and Prevalence of TMVR; 2014-2021 (‘000)
4.2.4 Europe TMVR Market by Value and Volume
Table 25: Europe TMVR Market by Value; 2015-2021 (US$ Million)
Table 26: Europe TMVR Market by Volume; 2015-2021 (Units)
5. Market Dynamics
5.1 Growth Drivers
5.1.1 Increase in Patients with Congenital Heart Disease and Rheumatic Fever
5.1.2 Low Success Rate of Repair in FMR Patients
Table 27: Global FMR Patients; 2014-2020 (‘000)
5.1.3 Aging Population
Table 28: Global Population Above 65 Years; 2010-2015 (Million)
5.1.4 Increase in Prevalence of Mitral Valve Disease
Table 29: Prevalence of Mitral Valve Disease in the US by Age Group
5.1.5 Mitral Stenosis
5.2 Challenges
5.2.1 Patient Not Referred for Surgery
5.2.2 Complexity
5.2.3 Successful Surgical Repair
5.2.4 Risks to Surrounding Structures
5.3 Market Trends
5.3.1 Repair v/s Replacement
Table D: Repair v/s Replacement of Valve
5.3.2 Different Approaches
5.3.3 Types of Surgery
Table 30: Types of Surgery for MR
6. Competitive Landscape
6.1 Global TMVR Market by Players
Table E: Companies in the Global TMVR Market
6.2 Global TMVR Market by Key Players
Table F: Key Players in the Global TMVR Market: Overview
6.3 Comparison of Key Players in The Global TMVR Market by Design
Table G: Design Comparison of the Devices of Key Players in the Global TMVR Market
7. Company Profiling
7.1 Edward Lifecsiences Incorporation
7.1.1 Business Overview
7.1.2 Financial Overview
Table 31: Edward Lifesciences Net sales; 2011-2015 (US$ Billion)
Table 32: Edward Lifesciences Net sales by Segments; 2015
7.1.3 Business Strategy
7.2 Abbott Laboratories
7.2.1 Business Overview
7.2.2 Financial Overview
Table 33: Abbott Laboratories Net Sales; 2011-2015 (US$ Billion)
Table 34:Abbott Laboratories Net Sales by Segments; 2015
7.2.3 Business Strategy
7.3 Medtronic
7.3.1 Business Overview
7.3.2 Financial Overview
Table 35: Medtronic Net Sales; 2011-2015 (US$ Billion)
Table 36: Medtronic Net Sales by Segments; 2015
7.3.3 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report